Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast

21 Feb 2023 11:00 CET

Oslo, Norway, 21 February 2023

Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for
the second half and full year 2022 on Tuesday, 28 February 2023.

A presentation by Nordic Nanovector's interim CEO & CFO, Ludvik Sandnes, will be
held in-person and webcast live beginning at 8:30am CET.

VENUE: ADVOKATFIRMAET CLP DA, Sommerrogata 13, 0255 Oslo

Questions can be submitted in advance to ir@nordicnanovector.com

The webcast can be accessed from www.nordicnanovector.com in the section:
Investors & Media and a recording will also be available on this page after the
event.

The results report and the presentation will be available at
www.nordicnanovector.com in the section: Investors & Media/Reports and
Presentation/Interim Reports/2022 from 7:00am CET the same day.

IR enquiries

Ludvik Sandnes, Interim CEO & CFO
+47 907 43 017

ir@nordicnanovector.com

About Nordic Nanovector

Nordic Nanovector is committed to develop and deliver innovative therapies to
patients to address major unmet medical needs and advance cancer care.

Further information can be found at
www.nordicnanovector.com (https://nam10.safelinks.protection.outlook.com/?url=ht
t
p%3A%2F%2Fwww.nordicnanovector.com%2F&data=05%7C01%7Cmark.swallow%40medistrava.c
o
m%7C0b5d55887fcc4bddd24108db03d8d2c1%7C5c24475f929349d0b4e1ba6d190e92f9%7C0%7C0%
7
C638108002017583559%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIi
L
CJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=8ttx4sNkxIXKbRtEA7RQp%2FvHln
2
4QCaKkOEaehniofM%3D&reserved=0)

This information is subject to a duty of disclosure pursuant to Sections 4-2 and
5-12 of the Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site